← All stories
Markets
BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration
Clinical collaboration enables novel combinations of select BeOne oncology assets with four Revolution Medicines clinical-stage RAS(ON) inhibitors for RAS-addicted cancers Regional rights agreement provides BeOne with exclusive development…
Covered by 1 outlet
All coverage · 1 article